Page results
-
Occupational therapists support people to do activities which are important to them, but which may be difficult because of health conditions.
-
This information aims to answer your questions about a robotic prostatectomy.
-
Digital accessibility and sustainability drive a switch to online patient information at UCLH
-
The rhinology unit covers all aspects of nose and sinus disease including allergy, infection, inflammatory/mucosal conditions, breathing disorders and tumours.
-
Online form for beginning the sefl referral process at UCLH maternity services.
-
The FGM service provides consultations, assessments, and support and referral to other services where clinically indicated
-
The Dermatology Department at University College Hospital is located in the Mortimer Market Centre and is housed in a newly refurbished dedicated skin clinic area where we see all of our adult patients for their outpatient appointments as well as surgical procedures and phototherapy.
-
This page provides information for patients visiting the Inflammatory Bowel Disease clinic.
-
This information outlines the things that you need to take home after your robotic prostatectomy.
-
This information is for patients who are receiving radiotherapy to the prostate or prostate bed. It explains what the treatment involves, describes side-effects you may experience during and after treatment, and how best to cope with them.
File results
-
FOI/2023/0808 - Full blood count tests for chemotherapy cancer treatment
-
FOI/2023/0809 - Equality, Diversity and Inclusion staff spend/ improved patient outcomes
-
FOI/2023/0810 - Inflammatory Bowel Disease colorectal cancer colonoscopy surveillance endoscopy
-
FOI/2023/0811 - HIFU partial ablation/ prostate cancer detection
-
FOI/2023/0813 - Ulcerative colitis/ crohn's disease
-
FOI/2023/0815 - Birth data; live births/ stillbirths/ neonatal deaths
-
FOI/2023/0817 - Bed sores, pressure sores and pressure ulcers statistics
-
FOI/2023/0822 - Bank staff pay rates
-
FOI/2023/0827 - Consultation on future of EDS services
-
FOI/2023/0829 - Immunoglobulin treatments